Group 1: Market Performance - The Hang Seng Index rose by 0.17% to close at 25,818.93 points, while the Hang Seng Tech Index increased by 0.19% to 5,499.3 points, and the Hang Seng China Enterprises Index saw a slight increase of 0.01% to 8,915.12 points [2] - The total market turnover was HKD 92.52 billion, with southbound funds experiencing a net outflow of HKD 1.175 billion [2] Group 2: Stock Highlights - Semiconductor manufacturer SMIC saw a stock increase of 3.21%, while China Hongqiao rose by 2.34%, and Cheung Kong Infrastructure increased by 1.83%, leading the blue-chip stocks [4] - Baidu's stock was included in the Hong Kong Stock Connect, leading to a significant price increase of 24.81% at one point, closing at HKD 35.08, which is a 22.23% rise [11][16] - The stock adjustment for Baidu is expected to enhance liquidity and market attention, potentially positively impacting the company's valuation [16] Group 3: Industry Performance - The Hang Seng Industry Index showed mixed results, with the Utilities Index up by 0.7%, Materials Index up by 0.65%, and Financials Index up by 0.4%. Conversely, the Healthcare Index fell by 0.52%, Non-essential Consumer Index dropped by 0.45%, and the Industrials Index decreased by 0.12% [6] - The Wind concept sector exhibited varied performance, with the Integrated Circuit Industry Fund Index rising by 2.85% and the Integrated Circuit Index increasing by 2.71%, while the Sapphire Index fell by 3% [8] Group 4: Regulatory Developments - The Hong Kong government and the Securities and Futures Commission are advancing legislative proposals for regulating virtual asset trading and custody service providers, marking a significant step in enhancing the regulatory framework for virtual assets [20] - The proposed licensing system aims to balance market development, risk management, and investor protection, contributing to the establishment of a trustworthy and sustainable digital asset ecosystem in Hong Kong [21]

Group 1 - The core point of the news is that Baiaosaitu has been included in the Hong Kong Stock Connect list, leading to a significant increase in its stock price, which rose by 24.81% at one point and closed at 35.08 HKD, up 22.23% [5][6][9] - The inclusion in the Stock Connect is expected to open the stock to mainland investors, potentially attracting new capital and enhancing liquidity and market attention, which may positively impact the company's valuation [9] - The overall market performance on December 24 showed a slight increase in major indices, with the Hang Seng Index rising by 0.17% and the Hang Seng Technology Index by 0.19%, while the total market turnover was 925.2 billion HKD [1] Group 2 - Semiconductor stocks led the blue-chip gains, with SMIC rising by 3.21% and China Hongqiao by 2.34% [2] - The industry performance was mixed, with the utilities index up by 0.7% and the healthcare index down by 0.52% [3] - The concept sectors showed varied performance, with the integrated circuit industry fund index increasing by 2.85% [4]

Core Viewpoint - The Hong Kong stock market has shown significant gains, with several companies experiencing substantial increases in their stock prices, indicating a positive market sentiment and potential investment opportunities. Group 1: Stock Performance - Shinyeh Holdings (06038.HK) has seen a remarkable increase of 32.81% [1][2] - Elephant Holdings Group (08635.HK) has risen by 28.09% [1][2] - Tongyuan International (03830.HK) has gained 25.00% [1][2] - Weiye Holdings (01570.HK) has increased by 23.40% [1][2] - Baiaosaitu-B (02315.HK) has experienced a rise of 22.23% [1][2] - Dongyao Pharmaceutical-B (01875.HK) has grown by 19.05% [1][2] - Xinneng Low Carbon (00145.HK) has increased by 17.78% [1][2] - China Shangcheng (02330.HK) has seen a rise of 17.71% [1][2] - Yingsheng Science (00209.HK) has gained 16.89% [1][2] - Base Champion Group (08460.HK) has increased by 16.82% [1][2]

Core Viewpoint - The company Biocytogen-B (02315) has announced that its shares listed on the Hong Kong Stock Exchange will be included in the Stock Connect program, effective December 24, 2025, allowing eligible investors from mainland China to invest directly in the company's H-shares [1] Group 1 - The inclusion of the company's H-shares in the Stock Connect program will expand its investor base [1] - This move is expected to enhance the trading liquidity of the company's H-shares [1]

公司H股获纳入港股通标的证券名单后，中国内地的合资格投资者将能够透过上海证券交易所及深圳证 券交易所直接投资于香港联交所上市的公司H股，此举有利于进一步扩大公司的投资者基础，并有望提 升公司H股的交易流动性。 百奥赛图-B(02315)发布公告，根据《上海证券交易所沪港通业务实施办法》及《深圳证券交易所深港 通业务实施办法》相关规定，公司发行并于香港联合交易所有限公司上市的股份将获纳入沪港通及深港 通(统称"港股通")项下的合资格证券，自2025年12月24日起生效。 ...

Core Viewpoint - The company, Baiaosaitu-B (02315.HK), announced that its H-shares will be included in the Stock Connect program, allowing eligible investors from mainland China to invest directly in its H-shares listed on the Hong Kong Stock Exchange starting from December 24, 2025 [1] Group 1 - The inclusion of the company's H-shares in the Stock Connect program is expected to expand its investor base [1] - This move is anticipated to enhance the trading liquidity of the company's H-shares [1]

香港交易及結算所有限公司及香港聯合交易所有限公司對本公告的內容概不負責，對其準確性 或完整性亦不發表任何聲明，並明確表示，概不就因本公告全部或任何部份內容而產生或因依 賴該等內容而引致的任何損失承擔任何責任。 BIOCYTOGEN PHARMACEUTICALS (BEIJING) CO., LTD. 百奧賽圖（北京）醫藥科技股份有限公司 （於中華人民共和國註冊成立的股份有限公司） （股份代號：2315） 本公司董事會（「董事會」）欣然宣佈，根據《上海證券交易所滬港通業務實施辦法》 及《深圳證券交易所深港通業務實施辦法》相關規定，本公司發行並於香港聯合交 易所有限公司（「香港聯交所」）上市的股份（「H股」）將獲納入滬港通及深港通（統 稱「港股通」）項下的合資格證券，自2025年12月24日起生效。 本公司H股獲納入港股通標的證券名單後，中國內地的合資格投資者將能夠透過 上海證券交易所及深圳證券交易所直接投資於香港聯交所上市的本公司H股，此 舉有利於進一步擴大本公司的投資者基礎，並有望提升本公司H股的交易流動性。 自願性公告 獲調入港股通證券名單 本公告乃由百奧賽圖（北京）醫藥科技股份有限公司（「本公司」）作出 ...

每经AI快讯，12月24日，截至发稿，百奥赛图-B(02315.HK)涨18.95%。根据深交所的公告，港股通标的 证券名单调整，调入百奥赛图-B，12月24日起生效。 ...

Group 1 - The stock of Baiaosaitu-B (02315.HK) surged nearly 20% in early trading, reaching a price of 34.3 HKD, with a trading volume of 22.7351 million HKD [2]

Group 1 - The core point of the article is that 百奥赛图-B (02315.HK) has seen its stock price increase by over 16% following its inclusion in the Hong Kong Stock Connect program, effective from today [1] Group 2 - The inclusion in the Hong Kong Stock Connect is expected to enhance the company's visibility and accessibility to a broader range of investors [1] - The stock price surge reflects positive market sentiment and potential growth opportunities for the company [1] - This development may lead to increased trading volume and liquidity for 百奥赛图-B in the Hong Kong market [1]